Alzheimer's disease (AD), Parkinson's disease (PD), and cancer (e.g., leukemia) are the most devastating disorders affecting millions of people worldwide. Except for some kind of cancers, no effective and/or definitive therapeutic treatment aimed to reduce or to retard the clinic and pathologic symptoms induced by AD and PD is presently available. Therefore, it is urgently needed to understand the molecular basis of these disorders. Since oxidative stress (OS) is an important etiologic factor of the pathologic process of AD, PD, and cancer, understanding how intracellular signaling pathways respond to OS will have a significant implication in the therapy of these diseases. Here, we propose a model of minimal completeness of cell death signaling induced by OS as a mechanistic explanation of neuronal and cancer cell demise. This mechanism might provide the basis for therapeutic design strategies. Finally, we will attempt to associate PD, cancer, and OS. This paper critically analyzes the evidence that support the “oxidative stress model” in neurodegeneration and cancer

Jimenez-Del-Rio, Marlene

Velez-Pardo, Carlos

English

PubMed

Alzheimer’s disease (AD), Parkinson’s disease (PD), and cancer (e.g., leukemia) are the most devastating disorders affecting millions of people worldwide. Except for some kind of cancers, no effective and/or definitive therapeutic treatment aimed to reduce or to retard the clinic and pathologic symptoms induced by AD and PD is presently available. Therefore, it is urgently needed to understand the molecular basis of these disorders. Since oxidative stress (OS) is an important etiologic factor of the pathologic process of AD, PD, and cancer, understanding how intracellular signaling pathways respond to OS will have a significant implication in the therapy of these diseases. Here, we propose a model of minimal completeness of cell death signaling induced by OS as a mechanistic explanation of neuronal and cancer cell demise. This mechanism might provide the basis for therapeutic design strategies. Finally, we will attempt to associate PD, cancer, and OS. This paper critically analyzes the evidence that support the “oxidative stress model” in neurodegeneration and cancer.</jats:p

Marlene Jimenez-Del-Rio

Carlos Velez-Pardo

Crossref

Oxidative Medicine and Cellular Longevity

The Bad, the Good, and the Ugly about Oxidative Stress

Alzheimer’s disease (AD), Parkinson’s disease (PD), and cancer (e.g., leukemia) are the most devastating disorders affecting millions of people worldwide. Except for some kind of cancers, no effective and/or definitive therapeutic treatment aimed to reduce or to retard the clinic and pathologic symptoms induced by AD and PD is presently available. Therefore, it is urgently needed to understand the molecular basis of these disorders. Since oxidative stress (OS) is an important etiologic factor of the pathologic process of AD, PD, and cancer, understanding how intracellular signaling pathways respond to OS will have a significant implication in the therapy of these diseases. Here, we propose a model of minimal completeness of cell death signaling induced by OS as a mechanistic explanation of neuronal and cancer cell demise. This mechanism might provide the basis for therapeutic design strategies. Finally, we will attempt to associate PD, cancer, and OS. This paper critically analyzes the evidence that support the “oxidative stress model” in neurodegeneration and cancer

Directory of Open Access Journals

(Kyoto Encyclopedia of Genes and Genomes) PATHWAY Database.

17β-Estradiol protects lymphocytes against dopamine and iron-induced apoptosis by a genomic-independent mechanism -

6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra,”

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor

A comparison of thiol peroxidase mechanisms,”

A doubleblind, placebo-controlled study to assess the mitochondriatargeted antioxidant MitoQ as a disease-modifying

A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine,”

A Drosophila model of Parkinson’s disease,”

A genetic cluster of early onset Parkinson’s disease in a Colombian population,”

a l l i w e la n dJ .M .C .G u t t e r i d g e ,Free Radicals in Biology and Medicine,

a l o p a ,J .B a s ,A .C a l l ´

A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from

a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg eﬀect,”

A pilot study of gene/gene and gene/environment interactions

A.D’alessandroandL.Zolla,“TheSODyssey:superoxidedismutasesfrombiochemistry,throughproteomics,tooxidative stress, aging and nutraceuticals,” Expert Review of Proteomics,

Abrams et al., “Molecular deﬁnitions of cell death subroutines: recommendations of the

actions, mechanisms, and potential therapeutic utility for Alzheimer disease,”

Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology,”

Activation of JNK and c-Jun is involved in glucose oxidase-mediated cell death of human lymphoma cells,”

Activation of nuclear transcription factor kappa B (NF-κB) is essential for dopamine-induced apoptosis in PC12 cells,”

Activation of stress activated protein kinase by MEKK1 phosphorylation of its activator

Activation of the IκBα kinase complex by MEKK1, a kinase of

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun Nterminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson’s disease and Dementia with Lewy bodies,”

Addressing reported pro-apoptotic functions of NF-κB: targeted inhibition of canonical NF-κB enhances the apoptotic eﬀects of doxorubicin,”

ADrosophila model for LRRK2-linked parkinsonism,”

Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress,”

Altered oxidative stress levels in Indian Parkinson’s disease patients with PARK2 mutations,”

Alzheimer’s disease facts and ﬁgures,”

American Parkinson’s and melanoma survey investigators. increased melanoma risk in Parkinson disease: a prospective clinicopathological study,”

An APAf-1 · cytochrome C multimeric complex is a functional apoptosome that activates procaspase-9,”

and chronic metal exposure impairs locomotion activity in Drosophila melanogaster:am o d e lt os t u d yP a r k i n -sonism,”

Antioxidant protection: apromising therapeutic intervention in neurodegenerative disease,”

Apoptosis in Parkinson’s disease: is p53 the missing link between genetic and sporadic

APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer’s disease,”

Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?”

Autosomal recessive juvenile Parkinsonism Cys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis,”

Avoidance of Aβ[25-35]/(H2O2)-inducedapoptosisinlymphocytesbythe cannabinoid agonists CP55,940 and JWH-015 via receptorindependent and PI3K-dependent mechanism: role of NFκB and p53,”

B a l e s ,Y .D u ,R .C .D o d e l ,G .M .Y a n ,E .H a m i l t o n -

Basic principles and emerging concepts in the redox control of transcription factors,”

Bioavailability of the polyphenols: status and controversies,”

Biochemistry of oxidative stress,”

Brigelius-Floh´ e et al., “Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy,”

c-Jun N-terminal phosphorylation correlates with activation of

c-Jun phosphorylation in Alzheimer disease,”

C.Velez-Pardo,G.Garcia-Ospina,andJ.M.DelRio,“Aβ[25– 35] peptide and iron promote apoptosis in lymphocytes by a common oxidative mechanism: involvement of hydrogen peroxide

Cancer cell killing via ROS: to increase or decrease, that is a question,”

Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain,”

Caspase-3: a vulnerability factor and ﬁnal eﬀe c t o ri na p o p t o t i cd e a t ho f dopaminergic neurons in Parkinson’s disease,”

Cell death pathways in Parkinson’s disease: proximal triggers, distal eﬀectors, and ﬁnal steps,”

Cell penetrating peptide inhibitors of nuclear factor-kappa

Challenges for research on polyphenols from foodsinAlzheimer’sdisease:bioavailability,metabolism,and cellular and molecular mechanisms,”

Classiﬁcation of cell death: recommendations of the NomenclatureOxidative Medicine and Cellular

Clinical neuroprotection in Parkinson’s disease—still waiting for the breakthrough,” JournaloftheNeurologicalSciences,vol.289,no.1-2,pp.104– 114,

crosstalk-a promising new therapeutic target,”

Crucial role of the amino-terminal tyrosine residue 42 and the carboxylterminal PEST domain of I kappa B alpha in NFkappa B activation by an oxidative stress,”

Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors,”

Dietary polyphenols: good, bad, or indiﬀerent for your health?”

DNA damage does not correlate with amyloid-β-plaques and neuroﬁbrillary tangles in familial Alzheimer’s disease presenilin1 [E280A] mutation,”

Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations,”

Doctors explain battle to beat Alzheimer’s,” CNN,

Drosophila as a model to study age-related neurodegenerative disorders:

Drosophila models of Parkinson’s disease,”

Dual roles of NFκB in cell survival and implications of NF-κB inhibitors

Eﬀects of insulin-like growth factor-1 on rotenone-induced apoptosis in human lymphocyte cells,” Basic and Clinical PharmacologyandToxicology,vol.106,no.1,pp.53–61,2010.

Elian et al., “A4T mutation in the SOD1 gene causing familial amyotrophic lateral sclerosis,”

enhances oxidative stress-induced neurotoxicity via its kinase activity,” Experimental cell research,

Epidemiology and etiology of Parkinson’s disease: a review of the evidence,”

Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimerdisease,”MetabolicBrainDisease,v ol.26,no .3,pp .

Evaluation of striatal oxidative stress in patients with Parkinson’s disease using

Forty years of superoxide dismutase research: the work of Irwin Fridovich,”

Gene-environment interactions: keytounravelingthemysteryofParkinson’sdisease,”Progress in

Geochemistry. A shot of oxygen to unleash the evolution of animals,”

Geology: the story of O2,”

Glucose metabolism in lymphocytes is a regulated process with signiﬁcant eﬀects on immune cell function and survival,”

Glutathione - A review on its role and signiﬁcance in Parkinson’s disease,”

Gr¨ undemann et al., “Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase,”

H.Ren,K.Fu,D.Wang,C.Mu,andG.Wang,“OxidizedDJ-1 interacts with the mitochondrial protein

Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense,”

How to standardize the multiplicity of methods to evaluate natural antioxidants,”

Human catalase: looking for complete identity,”

Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65. Evidence for the involvementofIκBαkinaseandSykprotein-tyrosinekinase,”Journal of

Hydrogen peroxide as a cell-survival signaling molecule,” Antioxidants and Redox Signaling,

Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin,”

Hydrogen peroxide stimulates proliferation and migration ofhumanprostatecancercellsthroughactivationofactivator protein-1 and up-regulation of the heparin aﬃn regulatory peptide gene,”

Hydrogen-rich saline reduces oxidative stress and inﬂammation by inhibit of JNK and NF-κB activation in a rat model of amyloid-beta-induced Alzheimer’s disease,”

I.E.Clark,M.W.Dodson,C.Jiangetal.,“Drosophilapink1is required for mitochondrial function and interacts genetically withparkin,”Nature,vol.441,no.7097,pp.1162–1166,2006.

In vivo imaging of reactive oxygen species speciﬁcally associated with thioﬂavine S-positive amyloid plaques by multiphoton microscopy,”

Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways,”

Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer’s disease,”

Insulin-like growth factor-1 prevents Aβ[25−−35]/ (H2O2)- induced apoptosis in lymphocytes by reciprocal NF-κB activation and

Interaction of genetic and environmental factors in a Drosophila parkinsonism model,”

Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer’s disease,”

Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2’ mapping,”

Involvement of oxidative stress in taxol-induced apoptosis in chronic myelogenous leukemiaK562cells,”ExperimentalandToxicologicPathology.

Iron-dependent functions of mitochondria—relation to neurodegeneration,”

IronaccumulationinAlzheimerdiseaseisasourceofredoxgenerated free radicals,”

Is NF-κB from astrocytes a decision maker of neuronal life or death? (Commentary on Dvoriantchikova et al.): commentary,”

Iyirhiaro et al., “Nuclear factorκB modulates the p53 response in neurons exposed to DNA damage,”

J¨ a n i c k e ,M .L .S p r e n g a r t ,M .R .W a t i ,a n dA .G . Porter, “Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis,”

JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer’s and various neurodegenerative abnormalities,”

The Bad, the Good, and the Ugly about Oxidative Stress

Abstract

Similar works

Full text

Available Versions

Crossref

Directory of Open Access Journals